GSK plc
GSK
#188
Rank
NZ$188.57 B
Marketcap
NZ$94.31
Share price
3.31%
Change (1 day)
43.35%
Change (1 year)

GSK plc (GSK) - Cash on Hand

Cash on Hand as of December 2025 : NZ$7.33 Billion

According to GSK plc's latest financial reports the company has NZ$7.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GSK plc - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$7.34 B-11.11%
2024-12-31NZ$8.26 B-17.82%
2023-12-31NZ$10.05 B-31.25%
2022-12-31NZ$14.62 B79.02%
2021-12-31NZ$8.17 B-29.89%
2020-12-31NZ$11.65 B30.54%
2019-12-31NZ$8.92 B19.21%
2018-12-31NZ$7.49 B0.64%
2017-12-31NZ$7.44 B-16.2%
2016-12-31NZ$8.88 B-30.53%
2015-12-31NZ$12.78 B46%
2014-12-31NZ$8.75 B-22.1%
2013-12-31NZ$11.24 B34.14%
2012-12-31NZ$8.37 B-28.66%
2011-12-31NZ$11.74 B-5.94%
2010-12-31NZ$12.48 B-19.26%
2009-12-31NZ$15.46 B-10.86%
2008-12-31NZ$17.35 B47.46%
2007-12-31NZ$11.76 B39.25%
2006-12-31NZ$8.44 B-36%
2005-12-31NZ$13.20 B23.37%
2004-12-31NZ$10.70 B12.7%
2003-12-31NZ$9.49 B25.53%
2002-12-31NZ$7.56 B-6.68%
2001-12-31NZ$8.10 B-33%
2000-12-31NZ$12.09 B99.02%
1999-12-31NZ$6.07 B2.2%
1998-12-31NZ$5.94 B26.42%
1997-12-31NZ$4.70 B53.82%
1996-12-31NZ$3.05 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
NZ$19.88 B 171.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$23.44 B 219.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$17.14 B 133.80%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$25.11 B 242.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.86 B 34.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$6.13 B-16.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ$1.11 B-84.77%๐Ÿ‡บ๐Ÿ‡ธ USA